Abstract
A common complication of stroke patients is post-stroke cognitive impairment （PSCI）， which significantly reduces their quality of life. Despite the fact that numerous drugs and therapeutic measures have been proved to suppress the activation of NLRP3 inflammatory bodies，their clinical efficacy and safety have not yet been confirmed.
Recommended Citation
Li, Xiaoxiao; Bai, Yanjie; Wang, Yan; and Zhang, Yongchuang
(2022)
"Advances of NLRP3 Inflammasome in Post-stroke Cognitive
Impairment,"
General Practice in China: Vol. 1:
Iss.
6, Article 3.
Available at:
https://www.gpinchina.net/journal/vol1/iss6/3
COinS
